Concerns of hybrid immunity and the way forward for adolescent COVID-19 vaccination


Pre-licensure scientific trials for the BNT162b2 COVID-19 vaccine confirmed prime efficacy amongst teenagers.

1

  • Frenck Jr, RW
  • Klein NP
  • Kitchin N
  • et al.
Protection, immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in teenagers.